Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2025-12-24 @ 4:01 PM
Study NCT ID:
NCT04422366
Status:
RECRUITING
Last Update Posted:
2024-06-07
First Post:
2020-05-17
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
Sponsor:
Shanghai Bovax Biotechnology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-28
Start Date Type:
ACTUAL
Primary Completion Date:
2027-09-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-09-15
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-17
First Submit QC Date:
None
Study First Post Date:
2020-06-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-06
Last Update Post Date:
2024-06-07
Last Update Post Date Type:
ACTUAL